February 9, 2022
Funding for the current CTSA grant ends in February 2023. Because we cannot guarantee uninterrupted pilot support until we know that NC TraCS funding is secure, we are suspending the TraCS $2K, $2K Stakeholder Engagement Voucher, FastTraCS, and $5-50K Pilot Programs for the time being.
January 20, 2022
This study, called IMPACT, was co-led by A. Wesley Burks, MD, CEO of UNC Health and dean of the UNC School of Medicine. Edwin Kim, MD, is co-author on the paper and leads peanut allergy research at the UNC School of Medicine.
January 5, 2022
NC TraCS Team Science is seeking to assist UNC researchers with the formation and development of multidisciplinary research teams focused on tackling challenging problems in clinical or translational medicine through our new Advancing Collaborative Team Research (ACTeR) Program. NC TraCS is currently accepting applications for Phase 1 ACTeR applications.
December 29, 2021
Kim Shoenbill, MD, PhD, at UNC Family Medicine and colleagues published the study "An Analysis of Inpatient Tobacco Use Treatment Transition to Telehealth" in Nicotine & Tobacco Research. The study provides the first analysis of inpatient tobacco use treatment during the transition to telehealth during the COVID-19 pandemic. It finds that telehealth services for inpatient populations resulted in a larger scope of patients reached and expanded participation in cessation counseling.
December 15, 2021
The Eshelman Institute for Innovation recently opened its pre-proposal application for the 2022 annual grant cycle. The Institute seeks to fund translational research related to therapeutics focused on oncology, infectious disease, and neuroscience, including rare diseases, and all digital health technologies. The Institute also welcomes ideas for devices and diagnostics, and other therapeutic areas and services.
December 7, 2021
TraCS Team Science is seeking to assist UNC researchers with the formation and development of multidisciplinary research teams focused on tackling challenging problems in clinical or translational medicine through the new ACTeR program. Support is provided through a combination of competitively reviewed graduated direct funding and logistical support.
November 23, 2021
The NC TraCS Pilot program has announced 3 new deadlines for $2K Pilot Awards submissions.
November 8, 2021
Jim Hagood, MD, Professor of Pediatrics, and Ronit Freeman, PhD, Associate Professor in Applied Physical Science, have been awarded a grant by Eshelman Institute for Innovation to pursue research in lung fibrosis.
November 2, 2021
Gracie Howell, Moderna COVID-19 vaccine clinical trial participant, continues her journey. Hear her story as she returns nine months later to receive her booster shot and why she values participating in COVID-19 research.
October 6, 2021
Leah Ranney, PhD, Director for Tobacco Prevention and Evaluation Program (TPEP) and team received a three-year NIH award in the amount of $1.2 million for the research study Strengthening Cigar Warnings to Prevent Adolescent Use.
September 29, 2021
The Program for Precision Medicine in Health Care will host an interactive mini-symposium exploring mechanisms for predicting how a patient's genome will influence their response to medications, implementing pharmacogenomics in the clinic, and development of EHR support.
August 17, 2021
On September 23 and 24, 2021, NC Biotech and FastTraCS are collaborating with health systems across North Carolina to provide a foundation for clinician innovation. This two-day virtual event puts an emphasis on action, connecting attendees with the people, insights, and strategies needed to systematically tackle the innovation process from ideation through execution.